News
2020
company
year
domain
Repertoire Immune Medicines Launches Type 1 Diabetes Focused Program with Investment from JDRF T1D Fund
Repertoire® Immune Medicines 03.25.2020
Seres Therapeutics Appoints Paul Biondi, Experienced Biopharmaceutical Strategy and Corporate Development Professional, to Its Board of Directors
Seres Therapeutics 03.23.2020